Published in Thromb Res on October 01, 1994
Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation (1991) 5.66
Effects of salicylates on human platelets. Lancet (1968) 4.59
The quantitation of platelet aggregation induced by four compounds: a study in relation to myocardial infarction. Thromb Diath Haemorrh (1966) 2.50
Effect of anti-inflammatory agents on platelets. Lancet (1968) 1.95
Treatment of Infective Hepatitis with Methionine. Br Med J (1945) 1.79
Platelet function studies before and after operation and the effect of postoperative thrombosis. J Lab Clin Med (1974) 1.74
Platelet function in venous thrombosis and low-dosage heparin. Lancet (1972) 1.53
Temperature and risk factors for ischaemic heart disease in the Caerphilly prospective study. Br Heart J (1993) 1.52
Refractory state of platelet aggregation with major operations. Lancet (1971) 1.48
The endothelial von Willebrand factor in venous occlusion blood. Thromb Haemost (1997) 1.43
"Rebleeding" the reversal of shear stress activation of platelets--a possible clue to thrombogenesis. Thromb Res (1992) 1.41
Puerperal thromboembolism and aspirin ingestion. Lancet (1970) 1.38
Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys. J Clin Pathol (1987) 1.31
Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study. Br Heart J (1982) 1.31
A comparison of an effect of different anti-inflammatory drugs on human platelets. J Clin Pathol (1970) 1.27
Platelet-bound and soluble platelet factor 4: effects of aggregating agents, of aggregation, and of aspirin. Proc Soc Exp Biol Med (1970) 1.16
Letter: Heparin thrombin clotting-time and platelet factor 4. Lancet (1974) 1.15
Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis. Thromb Diath Haemorrh (1975) 1.15
Two in-vivo studies comparing high and low aspirin dosage. Lancet (1971) 1.10
Letter: Platelet counts in normal pregnancy. J Clin Pathol (1976) 1.08
Vitamin B12 in the rat kidney. Evidence for an association with lysosomes. Arch Biochem Biophys (1970) 1.08
Gender and employment grade differences in blood cholesterol, apolipoproteins and haemostatic factors in the Whitehall II study. Atherosclerosis (1993) 1.07
Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. Circulation (1991) 1.05
Exercise, fibrinogen, and other risk factors for ischaemic heart disease. Caerphilly Prospective Heart Disease Study. Br Heart J (1993) 1.04
Anti-thormbin III and heparin clotting times in thrombosis and atherosclerosis. Thromb Diath Haemorrh (1974) 1.01
Acute platelet changes after large meals of saturated and unsaturated fats. Lancet (1976) 1.01
Superconductivity in heavy alkaline-Earth intercalated graphites. Phys Rev Lett (2007) 1.00
Effect of aggregating agents and their inhibitors on the mean platelet shape. J Clin Pathol (1966) 0.98
Effect of a diet of polyunsaturated fats on some platelet-function tests. Lancet (1976) 0.98
Heparin neutralizing activity test in the diagnosis of acute myocardial infarction. J Clin Pathol (1975) 0.98
Dietary depletion of vitamin B12 and the excretion of methylmalonic acid in the rat. Br J Nutr (1969) 0.98
Platelet tests in the prediction of myocardial infarction and ischaemic stroke: evidence from the Caerphilly Prospective Study. Br J Haematol (2001) 0.96
Platelet functions in relation to diet and serum lipids in British farmers. Br Heart J (1981) 0.94
Effects of adenosine diphosphate and adrenaline on mean platelet shape. Nature (1965) 0.93
A nine-year survey of Fallopian tube dysfunction in human infertility. Diagnosis and therapy. Fertil Steril (1970) 0.91
Stressed template bleeding-time and other platelet-function tests in myocardial infarction. Lancet (1973) 0.89
Some interactions between human platelets and glass: von Willebrand's disease compared with normal. J Clin Pathol (1967) 0.89
Haemostatic factors and ischaemic heart disease. The Caerphilly study. Br Heart J (1985) 0.89
A comparison of platelet stickiness tests during an atromid-S trial. Thromb Diath Haemorrh (1966) 0.89
"Exhausted" platelets continue to circulate. Lancet (1978) 0.88
Bleeding time, stroke and myocardial infarction: the Caerphilly prospective study. Platelets (2003) 0.88
Platelet stickiness. Annu Rev Med (1966) 0.87
Cell membrane damage, platelet stickiness and some effects of aspirin. Br J Haematol (1969) 0.87
Effects of a fish oil supplement on serum lipids, blood pressure, bleeding time, haemostatic and rheological variables. A double blind randomised controlled trial in healthy volunteers. Atherosclerosis (1987) 0.87
The Haldane Haemoglobinometer. Br Med J (1944) 0.86
Platelet function in acute myocardial infarction patients compared with controls. Thromb Haemost (1980) 0.85
The association of platelet and red cell count with platelet impedance changes in whole blood and light-scattering changes in platelet rich plasma: evidence from the Caerphilly Collaborative Heart Disease Study. Thromb Haemost (1990) 0.85
A Clinical Evaluation of Some Tests of Liver Function. Br Med J (1944) 0.85
The mechanisms of venous thrombosis. Anticoagulants, aspirin, and heparin. Mod Concepts Cardiovasc Dis (1973) 0.84
Coronary heart disease, fibrinogen, and plasma heparin neutralising activity. Lancet (1981) 0.84
Platelet function long after arterial and venous thrombosis. Thromb Diath Haemorrh (1974) 0.84
Comparison of the effect of heparin and citrate on platelet aggregation. J Clin Pathol (1969) 0.84
Platelet function: a guide to platelet membrane structure. Ser Haematol (1970) 0.83
Platelets in the prediction of thrombotic risk. Atherosclerosis (1982) 0.82
Fibrinogen catabolism in the surgically treated patient and in those with postoperative venous thrombosis. Correlation of plasma fibrinogen chromatographic findings with 125I-labeled fibrinogen scan findings. J Lab Clin Med (1977) 0.81
Platelets, aspirin, and cardiovascular disease. Postgrad Med J (1998) 0.80
Rate of fibrinogen turnover in thrombosis. Lancet (1972) 0.80
Intra-platelet platelet factor 4 (IP.PF4) and the heparin-mobilisable pool of PF4 in health and atherosclerosis. Thromb Haemost (1984) 0.80
How does low-dose heparin prevent thrombosis? Lancet (1980) 0.80
Effect of salicylates on human platelets. Lancet (1968) 0.80
Heparin, platelets, and venous thrombosis. Am Heart J (1973) 0.80
Platelet responses to cardiopulmonary bypass. Assessment by a shear stress activation technique. J Cardiovasc Surg (Torino) (1992) 0.79
Heart valve stenosis and von Willebrand's factor multimers. Lancet (1992) 0.79
Inter-relationships between haemostatic tests and the effects of some dietary determinants in the Caerphilly cohort of older men. Blood Coagul Fibrinolysis (1993) 0.79
Unconventional T-H phase diagram in the noncentrosymmetric compound Yb2Fe12P7. Phys Rev Lett (2010) 0.79
Intraplatelet serotonin and plasma 5-hydroxyindoles in health and disease. Blood (1981) 0.78
Ticlopidine - an antiplatelet drug: effects in human volunteers. Thromb Res (1978) 0.78
Platelet adhesion and aggregation. Br Med J (1972) 0.78
Platelets and the vessel wall: how much aspirin? Lancet (1980) 0.78
Platelet and other tests followed sequentially for 14 days after operation. Clin Lab Haematol (1984) 0.78
Blood group, von Willebrand's factor and heart disease. Thromb Res (1990) 0.78
The platelets in glandular fever and idiopathic thrombocytopenic purpura. Br J Haematol (1978) 0.77
Letter: A relationship between platelet volume and platelet number. Thromb Diath Haemorrh (1974) 0.77
A comparison between the plasma concentration of immunologically assayed platelet factor 4 and beta-thromboglobulin and the heparin thrombin clotting time. Thromb Res (1979) 0.77
Heparin and platelets. Curr Ther Res Clin Exp (1975) 0.76
Platelet aggregation and incident ischaemic heart disease in the Caerphilly cohort. Heart (1998) 0.76
Letter: Adjustment to low-dose heparin to prevent thrombosis. Br Med J (1975) 0.75
Susceptibility to aspirin bleeding. Br Med J (1970) 0.75
Vaginitis: its diagnosis and treatment. Can Fam Physician (1970) 0.75
Letter: Intermittent calf compression in prevention of deep venous thrombosis. Br Med J (1974) 0.75
Heat treatment in von Willebrand's disease. Br Med J (Clin Res Ed) (1985) 0.75
Changes in the heparin neutralising activity of platelet poor plasma after immunisation. J Clin Pathol (1979) 0.75
The use of pool cryoglobulin factor 8 concentrate in the management of haemophilia. Proc R Soc Med (1967) 0.75
Some effects of mucopolysaccharide stains on platelet aggregation. J Clin Pathol (1970) 0.75
New directions in anticoagulant and antiplatelet treatment. Heart (1996) 0.75
Causes of birth asphyxia and trauma. Can Med Assoc J (1966) 0.75
Platelet aggregation and plasma-fibrinogen. Lancet (1969) 0.75
Arvin and platelets. Lancet (1969) 0.75
Aspirin, thrombosis, and the future. Lancet (1971) 0.75
Anti-inflammatory drugs and the prevention of thrombosis. Acta Med Scand Suppl (1971) 0.75
Anti-aggregants in clinical practice. Acta Clin Belg (1975) 0.75
Some effects of mucopolysaccharide stains on platelets. Acta Med Scand Suppl (1971) 0.75
On the value of using many different platelet "adhesiveness" tests. Thromb Diath Haemorrh Suppl (1967) 0.75
Aspirin against arterial and venous thrombosis. Lancet (1971) 0.75
Detection of thrombosis with iodine-125 fibrinogen. Data reassessed. Lancet (1970) 0.75
Platelet-function tests and clofibrate. Lancet (1968) 0.75
Factors influencing the optical platelet aggregation test. Acta Med Scand Suppl (1971) 0.75
Effect of cold on bleeding. Lancet (1971) 0.75
Operative treatment of Fallopian tube pathology in human fertility. Am J Obstet Gynecol (1969) 0.75
Prostaglandins and platelets. Lancet (1968) 0.75